Ep 45 Running a Clinical Study Without Millions

Cancer treatments are becoming more effective, but many carry serious cardiac side effects that can delay care and threaten patient health. In this episode, Key Tech's Andy Rogers talks with Skribe Medical CEO and co-founder Ryan Neely about the company's wearable ultrasound patch designed to help oncologists quickly detect cardiotoxicity in the clinic. They discuss rapid prototyping, early clinical testing, fundraising, and how wearable technology could improve cancer treatment outcomes through faster and eventually predictive monitoring. Watch the full conversation to learn how Skribe Medical is turning early data into a promising new tool for oncology care.